Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells.

By Xiao-Xia Jiang, Yi Zhang, Bing Liu, Shuang Zhang, Ying Wu, Xiao-dan Yu, N. Mao. Blood, 2005

1,346 citations recorded by the source corpus.

Subfields: Genetics, Immunology

View Paper: https://www.semanticscholar.org/paper/f64fe92c09672686a9b3067f400bd74772e7dc91

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Genetics

1. Jaehyup Kim
2. Frank Barry
3. P. Hematti
4. Oliver Soehnlein
5. M. Perretti
6. A. Ortega-Gómez

In Immunology

1. Jaehyup Kim
2. Vito Pistoia
3. L. Moretta
4. Antonio Uccelli
5. P. Hematti

Citations in the corpus

• Mesenchymal stem cells avoid allogeneic rejection (2005, background): “Similarly Jiang et al reported that MSC maintain DC in an immature state[26] and show that MSC inhibit up regulation of IL-12p70 [26].”
• Immunobiology of mesenchymal stem cells (2013, background): “MSCs retain dendritic cells (DCs) in an immature state by inhibiting the expression of MHC class II, CD1-a, CD40, CD80 and CD86, and by suppressing proinflammatory cytokine production.(38) TNF-a-stimulated MSCs can recruit more”
• Mesenchymal stem cells in health and disease (2008, background): “MSCs have been shown to inhibit the maturation of monocytes, and cord-blood and CD34 + haematopoietic progenitor cells into DCs in vitro”